INVO Bioscience Inc. (INVO) - Ekuitas Perusahaan

INVO Bioscience, Inc. (INVO) offers an innovative method for in vivo embryo maturation, making infertility treatment more accessible. The company is expanding its network of clinic partnerships to implement INVOcell systems, thereby optimizing IVF costs. The business is currently revising its strategy to move away from narrow specialization through a merger with a medical center operator, while the indicator stands at -0.01. The asset's market dynamics are presented below.

INVO Bioscience, Inc. (INVO) - Nilai Buku Perusahaan saka 04.07.2022 nganti 28.04.2025

Rincian metrik keuangan lan pasar INVO Bio (INVO)

- rega lan prakiraan konsensus rega:

Bagan rega INVO Bioscience, Inc.|INVO - Bagan rega target

- data kapitalisasi pasar:

Nilai pasar INVO Bioscience Inc.|INVO - Nilai Total Perusahaan

- data kapitalisasi buku:

Aset Bersih saben Saham INVO Bioscience|INVO - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Aset Bersih invobioscience.com|INVO - Total Aset Perusahaan

- data utang lan likuiditas:

Utang marang Modal INVO Bioscience, Inc.|INVO - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas INVO Bioscience, Inc.|INVO - Gunggung utang perusahaan|Utang-utang marang aset resik INVO Bioscience Inc.

Ringkesan analitik perusahaan:INVO - INVO Bioscience

For INVO Bioscience, Inc. (INVO), which automates incubation in reproductive medicine, book capitalization dynamics serve as an indicator of the real value of net assets minus liabilities. Daily recalculations of market data consensus allow investors to track hardware system depreciation and the efficiency of technology capitalization, where a high margin of safety minimizes shock risks but may limit overall investment returns.

Analisis pesaing INVO Bioscience, Inc.